National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Cannabidiol
Synonyms

Cannabidiol

CANNABIDIOL

1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-

CBD

CBD Oil

Epidiolex

GWP42003-P

Definitions

A phytocannabinoid derived from Cannabis species, which is devoid of psychoactive activity, with analgesic, anti-inflammatory, antineoplastic and chemopreventive activities. Upon administration, cannabidiol (CBD) exerts its anti-proliferative, anti-angiogenic and pro-apoptotic activity through various mechanisms, which likely do not involve signaling by cannabinoid receptor 1 (CB1), CB2, or vanilloid receptor 1. CBD stimulates endoplasmic reticulum (ER) stress and inhibits AKT/mTOR signaling, thereby activating autophagy and promoting apoptosis. In addition, CBD enhances the generation of reactive oxygen species (ROS), which further enhances apoptosis. This agent also upregulates the expression of intercellular adhesion molecule 1 (ICAM-1) and tissue inhibitor of matrix metalloproteinases-1 (TIMP1) and decreases the expression of inhibitor of DNA binding 1 (ID-1). This inhibits cancer cell invasiveness and metastasis. CBD may also activate the transient receptor potential vanilloid type 2 (TRPV2), which may increase the uptake of various cytotoxic agents in cancer cells. The analgesic effect of CBD is mediated through the binding of this agent to and activation of CB1.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C118452

CAS_Registry

13956-29-1

code

C118452

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C183079

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173383

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C177537

Contributing_Source

CTRP

DIPG/DMG

FDA

GDC

DEFINITION

A phytocannabinoid derived from Cannabis species, which is devoid of psychoactive activity, with analgesic, anti-inflammatory, antineoplastic and chemopreventive activities. Upon administration, cannabidiol (CBD) exerts its anti-proliferative, anti-angiogenic and pro-apoptotic activity through various mechanisms, which likely do not involve signaling by cannabinoid receptor 1 (CB1), CB2, or vanilloid receptor 1. CBD stimulates endoplasmic reticulum (ER) stress and inhibits AKT/mTOR signaling, thereby activating autophagy and promoting apoptosis. In addition, CBD enhances the generation of reactive oxygen species (ROS), which further enhances apoptosis. This agent also upregulates the expression of intercellular adhesion molecule 1 (ICAM-1) and tissue inhibitor of matrix metalloproteinases-1 (TIMP1) and decreases the expression of inhibitor of DNA binding 1 (ID-1). This inhibits cancer cell invasiveness and metastasis. CBD may also activate the transient receptor potential vanilloid type 2 (TRPV2), which may increase the uptake of various cytotoxic agents in cancer cells. The analgesic effect of CBD is mediated through the binding of this agent to and activation of CB1.

Display_Name

Cannabidiol

FDA_UNII_Code

19GBJ60SN5

FULL_SYN

Cannabidiol

CANNABIDIOL

1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-

CBD

CBD Oil

Epidiolex

GWP42003-P

Is_Value_For_GDC_Property

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1909

label

Cannabidiol

Maps_To

Cannabidiol

NCI_Drug_Dictionary_ID

765192

PDQ_Closed_Trial_Search_ID

765192

PDQ_Open_Trial_Search_ID

765192

Preferred_Name

Cannabidiol

prefixIRI

Thesaurus:C118452

Semantic_Type

Organic Chemical

Pharmacologic Substance

UMLS_CUI

C0006863

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1742

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2189

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C105578

Delete Subject Author Type Created
No notes to display
Create mapping

Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_69478 DRON LOOM
https://go.drugbank.com/drugs/DB09061 MDM LOOM
http://purl.obolibrary.org/obo/CHEBI_69478 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_69478 FIDEO LOOM
http://purl.obolibrary.org/obo/CHEBI_69478 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_69478 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_69478 DDSS LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000765192 PDQ LOOM
http://purl.bioontology.org/ontology/RXNORM/2045371 RXNORM LOOM
http://purl.obolibrary.org/obo/OMIT_0003524 OMIT LOOM
http://purl.obolibrary.org/obo/MESH_D002185 BERO LOOM
http://purl.bioontology.org/ontology/VANDF/4036658 VANDF LOOM
http://purl.obolibrary.org/obo/NCIT_C118452 BERO LOOM
http://purl.jp/bio/4/id/200906089429644213 IOBC LOOM
http://purl.bioontology.org/ontology/LNC/MTHU054884 LOINC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.455.849.090.100 RH-MESH LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/96223000 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/LNC/LP230023-6 LOINC LOOM
http://purl.bioontology.org/ontology/MESH/D002185 MESH LOOM
http://stirdf.jst.go.jp/id/200907020304049279 IOBC LOOM
http://www.phoc.org.cn/pmo/class/PMO_00017046 PMAPP-PMO LOOM
http://www.case.edu/EpilepsyOntology.owl#Cannabidiol EPSO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D002185 RH-MESH LOOM
http://purl.bioontology.org/ontology/ATC/N03AX24 ATC LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000193460 NDFRT LOOM
http://purl.bioontology.org/ontology/SNMI/C-63A23 SNMI LOOM